PRESS RELEASE BY THE MINISTRY FOR SOCIAL DIALOGUE, CONSUMER AFFAIRS AND CIVIL LIBERTIES – Minister Helena Dalli urges the Maltese scientific community to take part in Innovative Medicines Initiative projects

Minister for Social Dialogue, Consumer Affairs and Civil Liberties Helena Dalli addressed a seminar organised by the Medicines Authority about the Innovative Medicines Initiative (IMI) that was set up to address situations of diseases and conditions for which there is no adequate treatment, such as amyotrophic lateral sclerosis (ALS).

Minister Dalli said that IMI was a pioneer in creating a more open, collaborative approach to research between key players, including universities, pharmaceutical industries, small- and medium-sized enterprises, patients organisations, and medicines regulators.

“It would be a win-win situation for Malta and Europe if the Maltese scientific community were to be part of IMI projects”, added Minister Dalli.

Helena Dalli encouraged Maltese scientists to work closely with the Medicines Authority and to participate in ground-breaking projects that aim to deliver tangible benefits for patients, including the right pevention and treatment through innovative initiatives.

Minister Dalli said that, following the setting up of a unit of Medicines Intelligence and Access within the Medicines Authority, the Ministry for Social Dialogue has supported the setting up of a new unit on research, scientific affairs, and innovation.

IMI is a partnership between the European Union and the European pharmaceutical industry with a Euros 3.3 billion budget, currently running over 50 projects covering specific health issues such as neurological conditions, diabetes, oncology, and obesity.

Source: Government of Malta

PRESS RELEASE BY THE MINISTRY FOR SOCIAL DIALOGUE, CONSUMER AFFAIRS AND CIVIL LIBERTIES – Minister Helena Dalli urges the Maltese scientific community to take part in Innovative Medicines Initiative projects

Minister for Social Dialogue, Consumer Affairs and Civil Liberties Helena Dalli addressed a seminar organised by the Medicines Authority about the Innovative Medicines Initiative (IMI) that was set up to address situations of diseases and conditions for which there is no adequate treatment, such as amyotrophic lateral sclerosis (ALS).

Minister Dalli said that IMI was a pioneer in creating a more open, collaborative approach to research between key players, including universities, pharmaceutical industries, small- and medium-sized enterprises, patients organisations, and medicines regulators.

“It would be a win-win situation for Malta and Europe if the Maltese scientific community were to be part of IMI projects”, added Minister Dalli.

Helena Dalli encouraged Maltese scientists to work closely with the Medicines Authority and to participate in ground-breaking projects that aim to deliver tangible benefits for patients, including the right pevention and treatment through innovative initiatives.

Minister Dalli said that, following the setting up of a unit of Medicines Intelligence and Access within the Medicines Authority, the Ministry for Social Dialogue has supported the setting up of a new unit on research, scientific affairs, and innovation.

IMI is a partnership between the European Union and the European pharmaceutical industry with a Euros 3.3 billion budget, currently running over 50 projects covering specific health issues such as neurological conditions, diabetes, oncology, and obesity.

Source: Government of Malta